Due to its lack of progesterone receptor (PR), estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER-2), triple-negative breast cancer patients have a worse prognosis and tumors are more aggressive, and higher mortality 70. Here, ERBB2 is linked to triple-negative breast carcinoma.